Related Experiment Video
Updated: Jun 22, 2026
07:12
Mouse Naïve CD4+ T Cell Isolation and In vitro Differentiation into T Cell Subsets
Published on: April 16, 2015
The LIF cytokine: towards adulthood
Marina Trouillas1, Claire Saucourt, Bertrand Guillotin
1Université de Bordeaux, CNRS-UMR-5164-CIRID, 33076 Bordeaux, France.
European Cytokine Network
|June 23, 2009
Summary
Leukaemia inhibitory factor (LIF) is a cytokine with diverse physiological roles. Recent transcriptome analyses reveal new LIF targets in embryonic stem cells, suggesting further research into this complex molecule.
Area of Science:
- Cell Biology
- Molecular Biology
- Developmental Biology
Background:
- Leukaemia inhibitory factor (LIF) is a pleiotropic cytokine.
- LIF plays critical roles in embryonic stem cell pluripotency and differentiation.
- Despite decades of research, the full spectrum of LIF's functions remains incompletely understood.
Purpose of the Study:
- To summarize the essential characteristics of leukaemia inhibitory factor (LIF).
- To review the known physiological effects of LIF.
- To present recent findings and identify novel LIF targets.
Main Methods:
- Literature review of LIF's established roles.
- Analysis of recent scientific data and publications.
- Transcriptome analysis in murine embryonic stem (ES) cells and their derivatives.
Main Results:
- Identification of distinct categories of LIF target genes.
- Highlighting the complex regulatory network influenced by LIF.
- Characterization of LIF's impact on early cellular development.
Conclusions:
- LIF is a crucial cytokine with multifaceted biological activities.
- Transcriptome data provides new insights into LIF-mediated cellular processes.
- Further investigation is warranted to fully elucidate LIF's functions and therapeutic potential.
Related Concept Videos
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:21Lineage Commitment
Commitment is the process whereby stem cells:
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...